Indication intelligence, analysis and sector perception

RegMed Investors’ (RMi) pre-open: the first trading day of December

December 2, 2019 8:57am

A contrarian view is a protective stopcock

Lately, the health of the sector is based on algorithms than investor sentiment

Pre-open indications: I am still recommending taking some profits off the table

It’s an honor to be considered the “canary in the (sectors) coal mine”! I post about “indication intelligence” devoting my time to collection and analysis of information to assist investors in the perception of sector vulnerabilities and strengths – it’s more than opinion, the facts and truth need to be recognized!

Who is feeding your portfolio profits - RMi’s indicators or should be!

Dow futures are UP +04% (+12 points), S&P futures are UP +0.3% (+1 point) and NASDAQ futures are DOWN -0.07% (-5 points)

U.S. stock index futures rose as market participants monitored U.S.-China trade talks;

European markets were higher with the pan-European Stoxx 600 up +0.4% during mid-morning deals;

Asia Pacific markets rose as a private survey of Chinese factory activity in November came in stronger than expected, with the Caixin/Markit manufacturing Purchasing Managers’ Index for the month rising to 51.8;

Data Docket: ISM manufacturing and construction spending figures are due out at 10 a.m. ET.

Henry’omics:

Monday’s rising futures despite Chinese state media reporting Sunday that Beijing wants a cancellation of tariffs for a phase one trade deal.

There is no clear indication of when both countries will be able to sign an agreement as last week saw fresh tension between Washington and Beijing after President Trump signed legislation supporting protesters in Hong Kong.

The only long, I will consider is an elongated piece of Entenmamans as tensions exist between liquidity and fundamentals!

Friday night’s newsletter heading: “an early and positive sector close; still, selling into strength is a construct that won’t be regretted. Be prepared for the next weeks of algorithm’s retreats.”

Volume has stayed low while the IBB (+4.2%)and XBI (+5.53%) snaked higher last week with five (5) positive closes last week … I’d be nervous, no matter what or how high the markets move - today!

A quote from Friday, “There’s more room for profit-taking, but that doesn’t change my near-term view that the pain trade is a block away!”

Review the context of Q4’s market – so far:

December starts today …
November registered 1 holiday, 12 positive and 8 negative close;
October registered 10 positive, 1 neutral and 14 negative closes;

Companies in my headlights – It’s your decision; I provide an idea and context:

Pre-open indications: I am still recommending taking some profits off the table

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.